| Financial Year |
March 31 2023 |
| Monetary Funds |
6,134,971,853.52 |
| Held-for-trading Financial Assets |
200,145,950.10 |
| Notes Receivable |
664,526.74 |
| Accounts Receivable |
438,592,566.34 |
| Advances to Suppliers |
213,550,566.77 |
| Other Receivables |
21,592,779.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,559,580,130.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,268,035.05 |
| Total Current Assets |
9,732,701,365.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,207,140.73 |
| Investment Properties |
-- |
| Fixed Assetes |
951,409,746.46 |
| Under-construction Projects |
674,633,582.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,804,202,632.68 |
| R&D expenses |
-- |
| Goodwill |
1,226,538,018.74 |
| Long-Term Deferred and Prepaid Expenses |
225,239,854.99 |
| Deferred Income Tax Assets |
42,380,435.17 |
| Other Non-Current Assets |
685,644,251.67 |
| Sub-Total of Non-Current Assets |
5,642,313,434.43 |
| Total Assets |
15,375,014,800.33 |
| Short-Term Loans |
555,860,176.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,780,284.00 |
| Accounts Payable |
228,604,748.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
190,926,166.41 |
| Taxes Payable |
433,848,731.15 |
| Interest Payable |
1,108,450.23 |
| Dividend Payable |
490,000.00 |
| Other payables |
86,646,769.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
651,217,394.51 |
| Other Current Liabilities |
8,503,804.20 |
| Sub-Total of Current Liabilities |
2,278,855,864.93 |
| Long-term Loans |
756,806,820.50 |
| Bonds Payable |
105,690,017.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
91,321,955.27 |
| Deferred Income Tax Liabilities |
537,769,972.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,540,207,078.33 |
| Total Liabilities |
3,819,062,943.26 |
| Paid-In Capital(Or Share Stock) |
508,945,177.00 |
| Capital Surplus |
5,608,895,728.55 |
| Surplus Reserve |
105,563,360.26 |
| LESS:Treasury Stock |
12,319,680.00 |
| Undistributed Profits |
5,609,698,702.55 |
| Minority Stockholder's Interest |
20,291,787.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,535,660,069.54 |
| Owner's Equity（Stockholder's Equity） |
11,555,951,857.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,375,014,800.33 |
